Connect Sign InMolecular Subtypes of Endometrial Cancers: Approaches and Considerations for Testing
This presentation will provide you with the knowledge to approach molecular testing of endometrial cancers with confidence. Focusing on the TCGA molecular classifications of endometrial cancers and the benefits and challenges that have resulted from that study. Practical knowledge and shortcomings about the testing modalities used to classify tumors will be covered. We will also touch on some of the major clinical trials and treatment options for specific tumor types.
Lecture Presenter
Image
Valarie McMurtry, MD, PhD
Fellow, Cytopathology, University of Utah School of Medicine
Dr. Valarie McMurtry completed her undergraduate degree at the University of Oklahoma, followed by her medical degree and doctorate degree from Louisiana State University. Dr. McMurtry is certified by the American Board of Pathology in anatomic and clinical pathology.
Objectives
After this presentation, participants will be able to:
Discuss the reasoning and rationale for developing a molecular-based classification of endometrial cancers
Select correct testing and order of testing for clinical situations
Describe the testing considerations for each molecular classification
Discuss the recurrent genetic alterations for the molecular classifications
